Measles and rubella elimination in the Eastern Mediterranean Region: successes and challenges
- PMID: 31774131
- DOI: 10.26719/2019.25.10.667
Measles and rubella elimination in the Eastern Mediterranean Region: successes and challenges
Abstract
In 2019, upon reviewing countries' reports, the regional verification commission for measles and rubella elimination declared elimination of measles and rubella in Bahrain, Islamic Republic of Iran and Oman. This achievement in the Eastern Mediterranean Region (EMR) constitutes a major success, since it occurs at a time when there remain highly challenging situations in several countries of the Region. In addition, there are unprecedented high transmission rates of measles throughout the world, with other World Health Organization (WHO) regions either not progressing (status quo) or regressing. Indeed, the WHO Region of the Americas and several other countries have in fact lost the status of measles elimination.
Copyright © World Health Organization (WHO) 2019. Some rights reserved. This work is available under the CC BY-NC-SA 3.0 IGO license (https://creativecommons.org/licenses/by-nc-sa/3.0/igo).
Similar articles
-
Progress in measles and rubella elimination in Iran.Pediatr Infect Dis J. 2007 Dec;26(12):1137-41. doi: 10.1097/INF.0b013e3181462090. Pediatr Infect Dis J. 2007. PMID: 18043452
-
Research priorities for accelerating progress toward measles and rubella elimination identified by a cross-sectional web-based survey.Vaccine. 2019 Sep 10;37(38):5745-5753. doi: 10.1016/j.vaccine.2019.02.058. Epub 2019 Mar 18. Vaccine. 2019. PMID: 30898393 Free PMC article.
-
Strengthening routine immunization through measles-rubella elimination.Vaccine. 2018 Sep 5;36(37):5645-5650. doi: 10.1016/j.vaccine.2018.07.029. Epub 2018 Jul 21. Vaccine. 2018. PMID: 30041881 Free PMC article.
-
Measles and rubella in the World Health Organization European region: diversity creates challenges.J Infect Dis. 2003 May 15;187 Suppl 1:S191-7. doi: 10.1086/368336. J Infect Dis. 2003. PMID: 12721913 Review.
-
Measles and rubella microarray array patches to increase vaccination coverage and achieve measles and rubella elimination in Africa.Pan Afr Med J. 2020 Jan 3;35(Suppl 1):3. doi: 10.11604/pamj.supp.2020.35.1.19753. eCollection 2020. Pan Afr Med J. 2020. PMID: 32373254 Free PMC article. Review.
Cited by
-
Elimination of endemic measles and rubella transmission in Oman.IJID Reg. 2024 Sep 5;13:100437. doi: 10.1016/j.ijregi.2024.100437. eCollection 2024 Dec. IJID Reg. 2024. PMID: 39376668 Free PMC article.
-
The Problem with Delaying Measles Elimination.Vaccines (Basel). 2024 Jul 22;12(7):813. doi: 10.3390/vaccines12070813. Vaccines (Basel). 2024. PMID: 39066457 Free PMC article. Review.
-
Epidemiology of measles in southern Iran: trends, challenges, and vaccination insights.Ann Med Surg (Lond). 2024 Apr 3;86(6):3273-3280. doi: 10.1097/MS9.0000000000002004. eCollection 2024 Jun. Ann Med Surg (Lond). 2024. PMID: 38846899 Free PMC article.
-
Seroconversion rates following 2 doses of measles- mumps- rubella vaccination given at the ages 12 and 18 months: data for possible additional dose at older age.BMC Immunol. 2022 Jan 16;23(1):2. doi: 10.1186/s12865-021-00465-1. BMC Immunol. 2022. PMID: 35034609 Free PMC article.
-
Measles and rubella serosusceptibity among population vaccinated with different schedules: the potential impact on measles-rubella elimination in Iran.BMC Infect Dis. 2021 Mar 25;21(1):305. doi: 10.1186/s12879-021-05970-7. BMC Infect Dis. 2021. PMID: 33765968 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical

